Peter discusses the promising advancements in vaccine technology, emphasizing the importance of safety and regulatory approval. He highlights the potential for vaccines to be tested in other countries sooner than expected, while also mentioning a company with a strong track record in vaccine development for animals. The conversation underscores a cautious optimism about extending healthy human lifespans through innovative medical solutions.
